Document is current
Any future updates will be listed below
-
Authors
Ji, Yang
Ni, Chuangye
Shen, Yanjun
Xu, Zhenggang
Tang, Lei
Yu, Fei
Zhu, Lingbang
Lu, Hao
Zhang, Chuanyong
Yang, Shikun
Wang, Xuehao
-
Funding
Funding for this research was provided by:
Post-Doctoral Foundation of Jiangsu Province (2023ZB327)
the Major Program of the National Natural Science Foundation of China (31930020)
the National Natural Science Foundation of China (82272791)
the Major Program of Yili Clinical Medical Research Institute (yl2021zd04)
Jiangsu Provincial Medical Innovation Center (CXZX202203)
Jiangsu Provincial Medical Key Laboratory (ZDXYS202201)
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, and Nanjing Medical University
- License Information
-
More Information
Article History
Received: 27 December 2023
Accepted: 29 June 2024
First Online: 11 July 2024
Declarations
:
: This study was approved by the Medical Ethics Committee of the First Affiliated Hospital at Nanjing Medical University.
: The authors declare no competing interests.
